GILD compared with CVS: revenue, margins and what each company keeps, and the suppliers and customers both name

GILDGilead Sciences, Inc.

Mkt capRevenueRevenue

CVSCVS Health Corp

Mkt capRevenueRevenue

Compare

GILDGilead Sciences, Inc.

CVSCVS Health Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GILD

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±3.4%▲+3.06%×0.91

Q2 FY26±4.6%▼−2.58%×0.57

Q1 FY26±4.0%▼−2.04%×0.50

Feb 11 '26±4.6%▲+5.82%×1.26

CVS

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±4.9%▼−5.08%×1.04

Q1 FY26±5.7%▲+7.65%×1.35

= impliedGILD realized, solidCVS realized, hatchedOne scale, both sides: full bar = 8%× = |realized| ÷ impliedSource: market data

Feb 10 '26

±5.3%

▼−0.09%

×0.02

Oct 29 '25±4.5%▼−1.95%×0.42

GILDGilead Sciences, Inc.

171.08▲+3.30%· post 170.64

Mkt cap$211.7BRevenue$8.3BQ3 FY26Revenue$29.4BFY25

CVSCVS Health Corp

90.26▼−0.08%· post 90.66

ClosedOct 30 '26

Mkt cap$115.4BRevenue$106BQ2 FY26Revenue$402BFY25

Compare

ClosedOct 30 '26

GILDGilead Sciences, Inc.

CVSCVS Health Corp

171.08▲+3.30%post 170.64

Price

90.26▼−0.08%post 90.66

$211.7B

Mkt cap

$115.4B

Q3 FY26$8.3B

Revenue

$106BQ2 FY26

FY25$29.4B

Revenue

$402BFY25

GILD171.08▲+3.30%vsCVS90.26▼−0.08%ClosedOct 30 '26